Data gathering for the first natural history studies using U-IMD data has started
On the MetabERN Board Meeting 2019 it was agreed that U-IMD should demonstrate its capabilities by facilitating natural history studies, therefore the focus for data acquisition currently is directed at the following target diseases:
- Smith Lemli Opitz syndrome
- Tyrosinemia type 1
- MSUD
- Mukolipidosis type II/III